RED:NICE TA949 - Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over. NHSE commissioned. (Decision date - March 2024)
Red Drug Classifications
8. NHS England commissioned – to be used in line with NHSE commissioning intentions